{"id":"W51594977","doi":"10.14694/edbook_am.2012.32.197","title":"Establishing the Standard of Care for Patients with Newly Diagnosed and Recurrent Glioblastoma","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Oncology; Clinical trial; Randomized controlled trial; Internal medicine; Adjuvant; Dacarbazine; Standard of care; Dosing; Cancer; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003401102,0.0001009916,0.0005902105,0.00001619622,0.00007236169,0.000003642843,0.00006278879,0.00006206676,0.00004286457],"category_scores_gemma":[0.0006994839,0.00005533107,0.0002289065,0.00009741357,0.0009258564,0.00007670021,0.00002908024,0.0001259841,7.461117e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001059573,"about_ca_system_score_gemma":0.0007302414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000384824,"about_ca_topic_score_gemma":0.00001874381,"domain_scores_codex":[0.9988854,0.0000735213,0.0004807631,0.0001636271,0.0002262043,0.0001704953],"domain_scores_gemma":[0.9924895,0.006131715,0.0005484672,0.000158136,0.0005104158,0.0001617803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001377821,0.002103152,0.807269,0.00005802851,0.0002448228,9.594008e-8,0.002279836,0.000001140991,0.000001927642,0.0003789381,0.01868349,0.1676017],"study_design_scores_gemma":[0.003927284,0.0131674,0.8118146,0.00006673617,0.0003200656,0.000001294998,0.003702192,0.00000418127,0.00004351014,0.0000343316,0.166856,0.00006238628],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782147,0.001160373,0.00002493701,0.01933788,0.0002038369,0.0007164357,0.0000705667,0.000005031632,0.0002661782],"genre_scores_gemma":[0.9813496,0.0003867408,0.01540687,0.002284272,0.0002923595,0.0001551152,0.00005359678,0.00001163824,0.00005980779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1675393,"threshold_uncertainty_score":0.3411357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02842049355554417,"score_gpt":0.3951774383224095,"score_spread":0.3667569447668653,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}